LOINCActiveOrder

LOINC Code 94327-4: PhenX - human papillomavirus vaccine use protocol 100802

94327-4 is a LOINC code used to identify PhenX - human papillomavirus vaccine use protocol 100802 in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component PhenX - human papillomavirus vaccine use protocol 100802. It is commonly used with the system or sample type ^Patient.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component PhenX - human papillomavirus vaccine use protocol 100802. It is commonly used with the system or sample type ^Patient.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Order
  • Panel type: Panel
  • Method: PhenX

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

PhenX - human papillomavirus vaccine use protocol 100802
The interviewer asks the individual whether s/he ever received a human papillomavirus (HPV) vaccination. If the response is yes, the interviewer asks about number of shots received. If the participant answers "yes" to question 1, the interviewer should complete the rest of the protocol. If the participant answers "no," then the protocol is deemed complete. The PhenX Working Group notes that GARDASIL® is also known internationally as Silgard. European Medicines Agency. (2009, September 25). Silgard European Public Assessment Report. Waknine, Y. (2006, October 2). International approvalsSingulair and Gardasil/Silgard. Medscape Today. Note: GARDASIL® by Merck & Co. is approved by the U.S. Food and Drug Administration (FDA) for use in females ages 9-26 and males ages 9-26. Note: CERVARIX® is manufactured by GlaxoSmithKline Biologicals and approved by the FDA for use in females ages 10-25.
Pan; Panel; PANEL.PHENX; Panl; PhenX - HPV vaccine use protocol; Pnl; Point in time; Random

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

PhenX - human papillomavirus vaccine use protocol 100802PhenX - HPV vaccine use protocolPANEL.PHENX-Pt^PatientPhenX

Frequently asked questions

Code details

Code94327-4
SystemLOINC
Display namePhenX - human papillomavirus vaccine use protocol 100802
Short namePhenX - HPV vaccine use protocol
ComponentPhenX - human papillomavirus vaccine use protocol 100802
Property-
TimingPt
System (specimen)^Patient
Scale-
MethodPhenX
ClassPANEL.PHENX
StatusACTIVE
Order/ObservationOrder

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.68
Last changed2.68

Part names

PhenX - human papillomavirus vaccine use protocol 100802-Pt^PatientPhenXPoint in time (spot)

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.

LOINC Code 94327-4 | HealthAssure